A novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family()

Triggering receptor expressed on myeloid cells 2 (TREM2) homozygous mutations cause Nasu-Hakola disease, an early-onset recessive form of dementia preceded by bone cysts and fractures. The same type of mutations has recently been shown to cause frontotemporal dementia (FTD) without the presence of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerreiro, Rita, Bilgic, Basar, Guven, Gamze, Brás, José, Rohrer, Jonathan, Lohmann, Ebba, Hanagasi, Hasmet, Gurvit, Hakan, Emre, Murat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Genetic Reports Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898264/
https://www.ncbi.nlm.nih.gov/pubmed/23870839
http://dx.doi.org/10.1016/j.neurobiolaging.2013.06.005
Descripción
Sumario:Triggering receptor expressed on myeloid cells 2 (TREM2) homozygous mutations cause Nasu-Hakola disease, an early-onset recessive form of dementia preceded by bone cysts and fractures. The same type of mutations has recently been shown to cause frontotemporal dementia (FTD) without the presence of any bone phenotype. Here, we further confirm the association of TREM2 mutations with FTD-like phenotypes by reporting the first compound heterozygous mutation in a Turkish family.

Ejemplares similares